Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.11    0.0025 (2.33%)
Bid:
0.10
Ask:
0.12
Spread: 0.02 (20.00%)
Market Cap: £1.62m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Update re: FastBase

24 May 2018 07:00

RNS Number : 1109P
Gunsynd PLC
24 May 2018
 

Gunsynd plc

("Gunsynd" or the "Company")

Update re: FastBase

Further to the announcement of 2 February 2018 regarding Fastbase, Inc. ("FastBase"), a privately owned Danish SaaS (software as a service) company which Gunsynd is assisting with its proposed admission to trading on AIM, the Company has been provided with the following update by FastBase:

The proposed admission to trading on AIM of FastBase, which had previously been stated to be targeted for Q2 2018, has been delayed by a number of factors including a potential corporate transaction and the development of new software. In addition, FastBase is considering admission to the Standard Segment of the Main Market of the London Stock Exchange as a possible alternative to AIM but a final decision has yet to be made. A regulatory advisor for the admission to the London Stock Exchange has yet to be appointed. A further announcement will be made in due course.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

The directors of Gunsynd accept responsibility for this announcement.

 

Hamish Harris commented: "It is important for shareholders to understand that whilst we maintain regular dialogue with the companies we are involved with, with respect to potential transactions, decisions are ultimately made by those companies regarding timing and transaction details."

 

Contacts:-

 

Gunsynd plc:

 

Hamish Harris

+44 (0) 20 7440 0640

 

 

Nominated Adviser / NEX Exchange Corporate Adviser:

 

Cairn Financial Advisers LLP

 

James Caithie/Liam Murray

+44 (0) 20 7213 0880

 

 

Broker:

 

Peterhouse Corporate Finance

 

Lucy Williams

+44 (0) 20 7469 0930

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDAJMJTMBJTTMP
Date   Source Headline
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.